CR6351A - Composiciones estimulantes del crecimiento mejoradas - Google Patents

Composiciones estimulantes del crecimiento mejoradas

Info

Publication number: CR6351A
Authority: CR; Costa Rica
Prior art keywords: growth stimulating; improved growth; improved; stimulating compositions; formulation
Prior art date: 1998-11-04

Application number

CR6351A

Other languages

English (en)

Spanish (es)

Inventor

S Robins Daniel

Chung Shiu

J Kennedy Thomas

James Knight Peter

Jese Shao Zezhi

Original Assignee

Schering Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-11-04

Filing date

2001-04-20

Publication date

2003-11-20

2001-04-20 Application filed by Schering Corp filed Critical Schering Corp

2003-11-20 Publication of CR6351A publication Critical patent/CR6351A/es

Links

239000000203 mixture Substances 0.000 title abstract 3
230000004936 stimulating effect Effects 0.000 title 1
238000009472 formulation Methods 0.000 abstract 2
241001465754 Metazoa Species 0.000 abstract 1
241001494479 Pecora Species 0.000 abstract 1
241000282887 Suidae Species 0.000 abstract 1
FPQFYIAXQDXNOR-QDKLYSGJSA-N alpha-Zearalenol Chemical compound O=C1O[C@@H](C)CCC[C@H](O)CCC\C=C\C2=CC(O)=CC(O)=C21 FPQFYIAXQDXNOR-QDKLYSGJSA-N 0.000 abstract 1
229940124325 anabolic agent Drugs 0.000 abstract 1
239000003263 anabolic agent Substances 0.000 abstract 1
238000013270 controlled release Methods 0.000 abstract 1
230000009977 dual effect Effects 0.000 abstract 1
239000012729 immediate-release (IR) formulation Substances 0.000 abstract 1
239000007943 implant Substances 0.000 abstract 1
238000002347 injection Methods 0.000 abstract 1
239000007924 injection Substances 0.000 abstract 1
229960002300 zeranol Drugs 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
- A61K9/204—Polyesters, e.g. poly(lactide-co-glycolide)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Dermatology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Endocrinology (AREA)
Diabetes (AREA)
Bioinformatics & Cheminformatics (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Organic Chemistry (AREA)
Epidemiology (AREA)
Medicinal Preparation (AREA)
Fodder In General (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Feed For Specific Animals (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

CR6351A 1998-11-04 2001-04-20 Composiciones estimulantes del crecimiento mejoradas CR6351A (es)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US18594498A	1998-11-04	1998-11-04

Publications (1)

Publication Number	Publication Date
CR6351A true CR6351A (es)	2003-11-20

Family

ID=22683037

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CR6351A CR6351A (es)	1998-11-04	2001-04-20	Composiciones estimulantes del crecimiento mejoradas

Country Status (11)

Country	Link
AR (1)	AR025133A1 (fr)
AU (1)	AU777393B2 (fr)
BR (2)	BRPI9914996B8 (fr)
CA (1)	CA2348841C (fr)
CO (1)	CO5140100A1 (fr)
CR (1)	CR6351A (fr)
MY (1)	MY134868A (fr)
PE (1)	PE20001092A1 (fr)
TW (1)	TWI250027B (fr)
WO (1)	WO2000025743A2 (fr)
ZA (1)	ZA200103494B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20020131988A1 (en) *	1999-12-16	2002-09-19	Foster Todd P.	Pharmaceutical implant containing immediate-release and sustained-release components and method of administration
US6953586B1 (en) *	2000-06-08	2005-10-11	Ivy Animal Health, Inc.	Growth promoting pharmaceutical implant
EP4000688B1 (fr)	2020-11-19	2025-11-05	F.I.S.- Fabbrica Italiana Sintetici S.p.A.	Procédé pour la préparation d'acétate trenbolone ayant une distribution granulométrique définie
EP4001289B1 (fr)	2020-11-19	2023-05-03	F.I.S.- Fabbrica Italiana Sintetici S.p.A.	Procédé amélioré de préparation de trenbolone et/ou d'acétate de trenbolone
EP4001288B1 (fr)	2020-11-19	2025-05-07	F.I.S.- Fabbrica Italiana Sintetici S.p.A.	Procédé de préparation d'acétate de trenbolone présentant une distribution granulométrique définie et un habitus cristallin à plaques irrégulières hexagonales

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2573307B1 (fr) *	1984-11-22	1988-06-10	Virbac Ctre Rech Biolog	Implants anabolisants a liberation prolongee
US4670249A (en) *	1985-04-12	1987-06-02	International Minerals & Chemical Corp.	Growth-promoting compositions
US5219572A (en) *	1989-03-17	1993-06-15	Pitman-Moore, Inc.	Controlled release delivery device for macromolecular proteins
US5747060A (en) *	1996-03-26	1998-05-05	Euro-Celtique, S.A.	Prolonged local anesthesia with colchicine
US5874098A (en) *	1997-05-28	1999-02-23	Ivy Laboratories, Inc.	Pellet implant system

1999
- 1999-11-02 CO CO99069032A patent/CO5140100A1/es unknown
- 1999-11-02 WO PCT/US1999/023993 patent/WO2000025743A2/fr not_active Ceased
- 1999-11-02 AU AU30967/00A patent/AU777393B2/en not_active Expired
- 1999-11-02 BR BRPI9914996-6 patent/BRPI9914996B8/pt unknown
- 1999-11-02 CA CA002348841A patent/CA2348841C/fr not_active Expired - Lifetime
- 1999-11-02 TW TW088119044A patent/TWI250027B/zh not_active IP Right Cessation
- 1999-11-02 AR ARP990105535A patent/AR025133A1/es active IP Right Grant
- 1999-11-02 BR BR9914996-6A patent/BR9914996A/pt not_active IP Right Cessation
- 1999-11-03 PE PE1999001104A patent/PE20001092A1/es not_active IP Right Cessation
- 1999-11-03 MY MYPI99004773A patent/MY134868A/en unknown
2001
- 2001-04-20 CR CR6351A patent/CR6351A/es not_active Application Discontinuation
- 2001-04-30 ZA ZA200103494A patent/ZA200103494B/xx unknown

Also Published As

Publication number	Publication date
AU3096700A (en)	2000-05-22
CO5140100A1 (es)	2002-03-22
AU777393B2 (en)	2004-10-14
BRPI9914996A (pt)	2001-07-10
PE20001092A1 (es)	2000-10-31
BR9914996A (pt)	2001-07-10
AR025133A1 (es)	2002-11-13
WO2000025743A2 (fr)	2000-05-11
TWI250027B (en)	2006-03-01
CA2348841C (fr)	2007-04-17
BRPI9914996B1 (pt)	2011-11-01
WO2000025743A3 (fr)	2000-08-24
ZA200103494B (en)	2002-07-30
MY134868A (en)	2007-12-31
BRPI9914996B8 (pt)	2021-07-06
CA2348841A1 (fr)	2000-05-11

Similar Documents

Publication	Publication Date	Title
NI200500087A (es)	2007-07-24	Derivados 4-tetrazolyl-4 fenilpiperidina para el tratamiento del dolor
ES2344505T3 (es)	2010-08-30	Formulaciones antiparasitarias.
ES2603086T3 (es)	2017-02-23	Uso de la daptomicina
AR026986A1 (es)	2003-03-05	Implante farmaceutico con contenido de componentes de liberacion inmediata y liberacion sostenida y metodos de administracion
EP1713453A4 (fr)	2007-03-07	Systeme de liberation de medicament implantable comprenant des filaments ou des fils
AR014231A1 (es)	2001-02-07	DISPOSITIVO DE ADMINISTRACIoN OSMoTICA PARA LA ADMINISTRACIoN DE UN AGENTE BENEFICIOSO A UN ANIMAL.
ES2052542T3 (es)	1994-07-16	Composiciones de hormonas del crecimiento, de liberacion sostenida, para administracion por via parenteral y su uso.
ATE340581T1 (de)	2006-10-15	Verfahren zur behandlung von prostaterkrankungen unter verwendung von vitamin-d-formulierungen mit verzögerter und/oder verlängerter wirkstofffreigabe
AR098251A2 (es)	2016-05-18	Uso de aivlosin o de una sal de adición ácida del mismo farmacológicamente aceptada para la preparación de un medicamento de uso veterinario, un alimento para aves de corral o cerdos, una composición recubierta estable para ser agregada a dicho alimento y un medicamento de uso veterinario
ECSP045407A (es)	2005-01-03	Benzazoles sustituidos y el uso del mismo como inhibidores de quinasa raf
AR044236A2 (es)	2005-09-07	Uso de una composicion que comprende esporozoitos de eimeria vivos
AR018691A1 (es)	2001-11-28	Disposicion de implante de pellets para la liberacion inmediata y retardada de drogas antiparasitarias
CR6351A (es)	2003-11-20	Composiciones estimulantes del crecimiento mejoradas
BRPI0517719A (pt)	2008-10-21	composição veterinária transmucosal compreendendo detomidina
AR048806A1 (es)	2006-05-31	Uso de cariofilenos en la elaboracion de medicamentos y tratamiento de afecciones corporales de inflamacion y dolor inflamatorio
MX9205508A (es)	1993-07-01	Formulacion inyectable de liberacion prolongada y metodo para su preparacion.
ES2063574T3 (es)	1995-01-01	Metodo de tratamiento mejorado para el cancer.
AR019579A1 (es)	2002-02-27	USO DE UN INICIADOR DE LA RESPUESTA SEXUAL DEL SISTEMA NERVIOSO CENTRAL PARA LA FABRICACIoN DE UNA COMPOSICIoN FARMACÉUTICA PARA LA NORMALIZACIoN DE LA CRONOMETRACIoN DE LA RESPUESTA SEXUAL O PARA LA PROFILAXIS O REDUCCIoN DE LA LESIoN TISULAR GENITAL EN MAMíFEROS
ECSP993205A (es)	2000-06-19	Composiciones estimulantes del crecimiento mejoradas (caso aho948)
MX9304197A (es)	1994-02-28	Nuevo uso de dimero de lisozina y composiciones que lo contienen.
MX2021011550A (es)	2021-10-26	Formulaciones de pregabalina y uso de las mismas.
ES2992032T3 (es)	2024-12-05	Nuevo método de aplicación tópica de agentes veterinarios
AR072889A1 (es)	2010-09-29	Combinacion coccidicida para uso veterinario
AR037543A1 (es)	2004-11-17	Metodo para la terapia del cancer y composicion farmaceutica
Godbold Jr et al.	2017	Contraindications, special considerations, and precautions

Legal Events

Date	Code	Title	Description
2009-07-06	FC90	Application suspended